drugset
drugset / Trial / NCT01105780

JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study

NCT01105780 ↗

Phase 1 Completed 32 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to assess the safety, tolerability pharmacokinetics (how the drug is absorbed in the body, how it is distributed within the body and how it is removed from the body over time) and pharmacodynamics (the effects of the drug) of JNJ-41443532 in healthy male and female Caucasian and male Japanese participants.

Timeline

Start
2010-05
Primary completion
—
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-41443532 Small molecule 250 mg Oral

Indications

No indication recorded.